Efgartigimod in Anti-NMDA Receptor Encephalitis. | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efgartigimod in Anti-NMDA Receptor Encephalitis.	Neoplasms by Site, Neuroinflammatory Diseases, Paraneoplastic Syndromes, Nervous System, anti-NMDA receptor encephalitis, autoimmune disease, autoimmune disorder of the nervous system, brain disorder, central nervous system disorder, encephalitis, immune system disorder, neoplasm, nervous system disorder, neurodegenerative disease, paraneoplastic syndrome	Recruiting	Phase 2	2026-09-16		NCT07822776

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing Huaxin Hospital	2
Beijing Tongren Hospital	60
First Affiliated Hospital of Zhejiang University	201
Henan Provincial People's Hospital	95
Peking Union Medical College	33
Shandong Provincial Hospital	112
The Second Hospital of Hebei Medical University	26
Xijing Hospital	177

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Tongren Hospital,Capital Medical University, Beijing, Beijing 100730	Beijing	China	1